Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02119702 · ClinicalTrials.gov registry record

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

A clinical trial, sponsored by Harvard School of Public Health (HSPH).

Completed
Registry status
818
Enrollment target

NCT02119702 is a clinical trial that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 818 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02119702 has completed, sponsored by Harvard School of Public Health (HSPH).

COMPLETED
Registry status
818 participants
Enrollment target

Study Summary

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.

Trial Details

FieldValue
Enrollment Target 818 participants
Start Date 2014-04
Est. Completion 2025-05-31

What the Registry Record Tells You About NCT02119702

The ClinicalTrials.gov registry entry for NCT02119702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 818 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02119702 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02119702 about?

NCT02119702 is a clinical study titled "Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)". This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic ba...

What is the current status of trial NCT02119702?

This trial is currently completed. The enrollment target is 818 participants. The study started on 2014-04. Estimated completion is 2025-05-31.

Who is sponsoring clinical trial NCT02119702?

This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.